MediGene
Appearance
![]() | |
Company type | Stock company |
---|---|
MDG1 | |
Industry | Biotechnology |
Founded | 1994 |
Headquarters | Martinsried, Germany |
Key people | Prof Dolores J Schendel (CEO), Gerd Zettlmeissl (Chairman of the supervisory board) |
Website | www |
Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development.
External links